Anxiety and depression improve when insulin resistance is treated in patients whose mood symptoms share a metabolic driver. A diet high in sugar and fat produces inflammation that reaches the brain and dampens the dopamine system that governs motivation.
Can anxiety and depression improve unexpectedly when insulin resistance is treated? The question arises here because more than 90% of the patients seen in this urban interventional pain practice have metabolic dysfunction, and their mood symptoms move when their metabolism does.
What diet does to memory and mood
The extent to which diet affects the brain has been studied repeatedly, and a diet high in sugar and fat produces measurable effects on memory and mood. The mechanisms are not mysterious: inflammatory signaling reaching the brain, disrupted glucose availability, altered microbial production of neuroactive compounds, and effects on the dopamine system that governs motivation.
The dopamine connection
Chronic inflammation directly affects the dopamine system that drives motivation. That offers an explanation both for the reduced motivation seen in metainflammation and for the anhedonia so often accompanying diabetes and chronic pain. A patient described as unmotivated may be describing a neurochemical state rather than a character trait.
Why this matters in a pain practice
Anxiety and depression are routinely treated as comorbidities of chronic pain — understandable consequences of living with it. That framing is incomplete. Where all three share an inflammatory and metabolic driver, treating the metabolism can improve all three, and treating each separately can improve none of them durably.
What this does not mean
It does not mean anxiety and depression are metabolic conditions, or that psychiatric treatment is unnecessary. It means the metabolic contribution is worth measuring in anyone whose mood symptoms sit alongside pain and metabolic dysfunction, because it is treatable and it is routinely missed.
